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C-terminal binding protein (CtBP) has been shown to bind to a highly conserved five-amino-acid motif (PXDLS) located very close to the C-
terminus of adenovirus early region 1A proteins. It has also been demonstrated that amino acids C-terminal and N-terminal to this original
proposed binding site contribute to the interaction. However, conflicting evidence has been presented to show that acetylation of an adjacent lysine
residue in Ad5E1A may or may not influence binding. It has now been demonstrated here that acetylation of a lysine, equivalent to position 261 in
Ad12 E1A and position 285 in Ad5E1A, in a synthetic peptide disrupts the binding to CtBP1 and CtBP2 and alters the Ki of the peptide, indicative
of a reduction in the affinity of the peptide for CtBP1 and CtBP2, but only to a rather limited extent (less than 2-fold). The solution structures of
synthetic peptides equivalent to wild-type and acetylated forms of the Ad12 E1A peptide have been determined by proton NMR spectroscopy. The
wild-type form of the peptide adopts a series of β-turns over the region Val254–Arg262. Within the acetylated isoform, the β-turn conformation is
less extensive, Val260–Arg262 adopting a random confirmation. We conclude that secondary structure (β-turns) and an appropriate series of amino
acid side chains over an extended binding site (PXDLSXK) are necessary for recognition by CtBP, acetylation of lysine interfering with both of
these features, but not to such an extent as to totally inhibit interaction. Moreover, it is possible that the β-turn conformation at the C-terminus of
AdE1A contributes to binding to α importin and nuclear import. Acetylation of lysine 261 could disrupt interaction through structural
destabilization as well as charge neutralization and subsequent nuclear localization.
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Adenovirus early region 1A(AdE1A) is the first protein to be
expressed following viral infection. Its expression is also
essential for adenovirus-mediated cellular transformation
(Shenk, 1996; Gallimore and Turnell, 2001; Endter and Dobner,
2003; Berk, 2005). Two major forms of the protein are
expressed, translated from either 13S or 12S mRNAs. TheyAbbreviations:AcK/Aly,N-ε-acetyllysine; CtBP, C-terminal binding protein;
E1A, adenovirus early region 1A protein; GST, glutathione-S-transferase.
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doi:10.1016/j.virol.2006.05.004differ only by the presence of a short amino acid sequence
located towards the C-terminus of the larger molecule. AdE1A
primarily functions as a regulator of transcription through a
complex series of interactions with host cell proteins (Gallimore
and Turnell, 2001). During viral infection, it binds to
transcriptional co-activators, co-repressors and transcription
factors enhancing the expression of viral early region proteins
(Shenk, 1996), stimulating host cell cycle progression into S
phase (Braithwaite et al., 1983) or in the absence of AdE1B,
causing apoptosis (Rao et al., 1992; Debbas and White, 1993).
AdE1A binds to more than 30 cellular targets to produce these
effects (reviewed Gallimore and Turnell, 2001). Binding sites
for all of these molecules have been mapped to either the N-
terminal region or sequences conserved between AdE1As from
116 D. Molloy et al. / Virology 355 (2006) 115–126different viral serotypes (CR1–4) (Avvakumov et al., 2002,
2004). For example, the pRb family of transcriptional co-
repressors bind to CR1 and CR2, while p300/CBP interact with
the N-terminal region and CR1 (Dyson et al., 1992; Wang et al.,
1993; Eckner et al., 1994). Binding to both of these sets of
proteins is necessary for AdE1-mediated transformation, but
interaction with either is sufficient to initiate cell cycle
progression (Howe et al., 1990; Howe and Bayley, 1992;
Wang et al., 1993). A number of proteins associated with the
basic transcriptional machinery, such as TBP, ATFs and TAFs
bind to CR3, the sequence unique to the 13S AdE1A; these
interactions are essential for the expression of other Ad early
region proteins (reviewed Jones, 1995).
A further cellular target for AdE1A is C-terminal binding
protein (CtBP), which was originally isolated on the basis of its
interaction with the C-terminal region of Ad5E1A (Boyd et al.,
1993). The site of interaction for CtBP is a highly conserved
PXDLS sequence, present in all adenovirus E1As very close to
the C-terminus (Avvakumov et al., 2002, 2004, Boyd et al.,
1993; Schaeper et al., 1995). The same motif has since been
shown to be widespread in proteins expressed in insects,
amphibians and mammals. Most CtBP binding proteins are
involved in the regulation of transcription, and it appears that
CtBP largely functions as a transcriptional co-repressor
(reviewed Turner and Crossley, 2001; Chinnadurai, 2002,
2004). For example, Drosophila CtBP (dCtBP) binds to the
short- and long-range repressors Kruppel, Knirps, Snail, Hairy,
Hairless and zfh-1, regulating transcription, and ultimately
Drosophila embryo development (Nibu et al., 1998a,b;
Poortinga et al., 1998; Postigo and Dean, 2000, Morel et al.,
2001). In mammals, CtBP forms complexes with, for example,
the human polycomb protein hPC2 (Sewalt et al., 1999), the co-
repressors and repressors FOG-2 (Svensson et al., 2000) and
Ikaros (Koipally and Georgopoulos, 2000) and with the
Kruppel-like regulator BKLF (Turner and Crossley, 1998).
Additionally, CtBP associates with the family of histone
deacetylases (HDACs) in both a PXDLS-dependent and
-independent manner (Sundqvist et al., 1998; Subramanian
and Chinnadurai, 2003; Bertos et al., 2001). Although class II
HDACs contain possible PXDLS binding motifs, this is not the
case for other HDACs. However, recognition of this particular
series of interactions has led to the suggestion that this may be
one means by which CtBP is able to repress transcription
(Turner and Crossley, 2001; Chinnadurai, 2004).
While the five amino acids of the PXDLS sequence are the
major determinants of binding, other residues distinct from
these influence the interaction with CtBP. It has been
demonstrated that a number of different substitutions both N-
and C-terminal to the PXDLS of AdE1A can cause marked
differences in binding properties (Schaeper et al., 1995; Molloy
et al., 1998, 2001). For example, synthetic peptides with
identical PXDLS motifs, but with different adjacent sequences,
can have different Kis for the inhibition of the interaction
between CtBP1 and Ad12E1A (Molloy et al., 2001). In
addition, it has been shown that intact Ad12E1A will bind
CtBP1 with higher affinity than will Ad12E1A exon 2 and this,
in turn, will bind more strongly than a short peptide containingthe same PVDLS sequence (Molloy et al., 2001). Of particular
interest among the adjacent amino acids is a lysine residue,
highly conserved between E1As from different serotypes
(Avvakumov et al., 2004), that is situated two amino acids C-
terminal to the CtBP binding motif. This particular residue is a
site for acetylation by the histone acetyl transferases (HATs)
p300, P/CAF and Gcn5 each of which bind to AdE1A (Zhang et
al., 2000). Most significantly, acetylation of Lys239 in the Ad5
243 aa E1A protein is reported to inhibit interaction with CtBP
(Zhang et al., 2000) although alternative evidence has also been
presented to show that acetylation has little effect on the
interaction (Madison et al., 2002). Interestingly, Lys239 in
Ad5E1A also forms part of the AdE1A nuclear localization
signal (Lyons et al., 1987). The NLS in Ads comprises the
sequence KRPRP (Lyons et al., 1987) with Lys239 and Arg240
being most important (Douglas and Quinlan, 1996). Further-
more, acetylation at Lys239 has been reported to inhibit binding
of AdE1A to importin-α3 and favor cytoplasmic localization
(Madison et al., 2002). In light of these conflicting data, we
have examined the effect on CtBP binding of acetylation at a
residue very close to the PXDLS motif in Ad12E1A. While it is
possible that disruption of binding could involve steric
hindrance, we have considered the possibility that this
modification could also destabilize local structure within the
C-terminal region of AdE1A. We present here an analysis of
structures for wild-type and acetylated peptides equivalent to
the C-terminal region (encompassing the CtBP binding site) of
Ad12E1A and show that acetylation causes marked destabili-
zation of structural determinants at the C-terminus, although
this is largely limited to amino acids C-terminal to PVDLS,
suggesting that the site of interaction may be more extensive
than previously thought.
Results
It has previously been shown that integrity of the C-terminal
region of Ad12 E1A (aa 247–266) is essential for interactions
with CtBP1 (Molloy et al., 1998). Similarly, mutations in the
PXDLS motif and closely surrounding region of Ad5E1A are
deleterious to CtBP binding (Boyd et al., 1993; Schaeper et al.,
1995). As well as the primary binding site, post-translational
modification of an adjacent lysine residue is also considered to
be of importance (Zhang et al., 2000) although other reports
suggest this not to be the case (Madison et al., 2002). The
precise structural consequences of this acetylation for E1A,
however, remain unknown. Here, we have examined again
whether synthetic peptides equivalent to the C-terminus of wild-
type and acetylated forms of Ad5 and Ad12 E1A (Fig. 1) disrupt
interactions with CtBP1 and CtBP2. Additionally, we have
examined and compared structures for wild-type and acetylated
forms of a synthetic peptide equivalent to the C terminus of
Ad12 E1A, which comprises some, and perhaps most, of the
CtBP binding site (Fig. 1). Because of the controversial nature
of previously published data (Zhang et al., 2000; Madison et al.,
2002), we have adopted two approaches to the determination of
the effects of the acetylation of peptides equivalent to the C-
terminal regions of Ad5 and Ad12E1A on the interaction with
Fig. 1. Sequences of synthetic peptides used in this study. The amino acid sequences of synthetic peptides A5, A6, A7 and A8 equivalent to the C-terminal region of
Ad12 (A5 and A6) and Ad5 (A7 and A8) E1As are illustrated using the single letter code. The acetylated peptides are illustrated beneath their wild-type counterparts by
the inclusion of acetylated lysine (AcK) in place of lysine (K). The structures and atomic nomenclature for lysine and acetyllysine are illustrated.
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on GST pull-down assays; the second is a quantitative method
based on ELISAs, which allows a statistical analysis of the
binding data.
Interactions of wild-type and acetylated Ad E1A peptides with
CtBP1 determined using GST pull-down assays
The ability of synthetic peptides to disrupt Ad12 E1A
binding to GST-CtBP1 was assessed under conditions where
peptide was present at a concentration far in excess of either
GST-CtBP or E1A, as it has previously been demonstrated that
binding interactions are significantly lower for peptides, cf.,
intact E1A (Molloy et al., 1998; 2000, 2001; Zhang et al.,
2000). The effect of increasing concentration of wild-type Ad5
and Ad12 peptides and their acetylated counterparts upon CtBP.
E1A interactions is illustrated in Fig. 2. In the absence of any
peptide (Fig. 2A, lane 1), E1Awas detected together with GST-
CtBP in the supernatant after elution from glutathione agarose.
In the presence of increasing concentrations (of between 5 and
100 μg) of either A5 or A7 peptide GST-CtBP·E1A interactions
were disrupted, as evidenced by lower concentrations of E1A
detected after displacement of GST-CtBP with glutathione. For
example, in Fig. 2A, compare lane 1 with lanes 2, 6, 10 and 14
for the Ad12 wild-type peptide (A5) and lane 1 with lanes 4, 8,
12 and 16 for Ad5 wild-type peptide (A7). It is noteworthy that
GST-CtBP·E1A interactions were disrupted to a greater extent
in the presence of wild-type Ad12 peptide compared to wild-
type Ad5 (in the separate experiment shown in Fig. 2B compare
lane 1 with lane 2 and lane 4 and lane 2 with lane 4), but this
may be a function of using intact Ad12E1A protein in the
binding study.
We have assessed the impact of lysine acetylation within the
C terminus of E1A on GST-CtBP binding interactions. At high
(50–100 μg) concentrations, acetylated Ad12 peptide, A6 (Fig.
2A, lanes 3, 7, 11 and 15), and the Ad5 counterpart peptide, A8(Fig. 2A, lanes 5, 9, 13 and 17), once again reduced
concentrations of E1A which were detected when GST-CtBP1
was displaced with glutathione. Significantly, however, disrup-
tion of full-length E1A interactions with GST-CtBP1 in the
presence of acetylated peptides is less pronounced than for the
corresponding wild-type peptides (for example, compare lane 2
with lane 3 and lane 4 with lane 5 in a second experiment
presented in Fig. 2B). This is exemplified in a graphical
representation (Fig. 2C) of the data derived from densitometric
scanning of the Western blot shown in Fig. 2A where ‘best-fit’
of the data using the standard binding equation (Molloy et al.,
1998) evaluated the Ki of peptides A5, A6, A7 and A8 for
CtBP1 to be 3.5, 5.0, 6.5 and 8.5 × 10−6 M, respectively. These
competitive effects illustrate that acetylation of lysine results
approximately in a 1.4-fold reduction in binding interactions,
regardless of whether the peptide is equivalent to Ad5 or Ad12.
Overall, acetylation of lysine disrupts Ad5 peptide interactions
with CtBP1 approximately 1.7-fold more than the Ad12
counterpart peptide. Thus, although binding is reduced by
acetylation the effect is relatively subtle and not the total
disruption reported previously (Zhang et al., 2000). It should be
noted that the results of this pull-down study are semi-
quantitative and the data presented in Fig. 2C represents the
results of the densitometric scan of Fig. 2A. This was
representative of a number of similar experiments (e.g., that
shown in Fig. 2B).
Interactions of wild-type and acetylated AdE1A peptides with
CtBP1 and CtBP2 using ELISAs
To obtain a quantitative analysis of the effects of acetylation
on AdE1A C-terminal peptides binding to CtBP ELISAs were
used essentially as described previously (Molloy et al., 1998,
2000). The effects of increasing concentrations of peptides A5–
8 on the interaction of Ad12E1A with GST-CtBP1 or GST-
CtBP2 were determined, and the results are presented
Fig. 2. Western blot analysis of Ad12 13 S E1A complexes with GST-CtBP1 in the presence of acetylated and non-acetylated peptides. (A) Binding of Ad12 13 S E1A
to GST-CtBP1 (Experiment 1). GST-CtBP1 was mixed with Ad12 E1A, and complexes were precipitated with glutathione agarose beads. The bound E1A was
determined by Western blotting (see Materials and methods). Lane 1, Ad12 13 S E1A bound to GST-CtBP1 after elution from glutathione agarose beads; lanes 2–18,
Ad12 13 S E1A in the presence of peptides A5, A6, A7 and A8, respectively at concentrations of 5 μg (lanes 2–5), 25 μg (lanes 6–9), 50 μg (lanes 10–13) and 100 μg
(lanes 14–17) after elution from glutathione agarose beads; (lane 18) Ad12 E1A in the absence of GST-CtBP1 control. (B) The effect of a fixed concentration (50 μg)
of the acetylated and non-acetylated peptides on the binding of Ad12 13SE1A to GST-CtBP1 (Experiment 2). E1A·GST-CtBP1 complexes were precipitated on
glutathione agarose beads, and the amount of bound E1Awas determined byWestern blotting in the absence of (lane 1) and presence of 50 μg peptides A5, A6, A7 and
A8 (lanes 2–5, respectively); (C) inhibition of Ad12 13S E1A and CtBP1 interaction in the presence of synthetic peptides. The ability of synthetic peptides equivalent
to the wild-type and acetylated forms of the C terminus of Ad12 E1A and Ad5 E1A to inhibit the interaction between CtBP1 and Ad12 13S E1A was assessed by
densitometry of the Western blot shown in 2(A). The data for peptides A5 (x), A6 (▴), A7 (▪) and A8 (▾) have been plotted as absorption against peptide
concentration. The solid lines represent best fit of the data by the standard binding function, Y = Ymax·[L]/Kd + [L], where Y represents the absorption of E1A bound to
GST-CtBP1 in the presence of varying amounts of E1A peptide, [L], Kd represents the equilibrium binding constant, and Ymax represents the end point for the binding
interaction. The affinity of CtBP1 for synthetic peptides was measured by competition with native E1A giving values for Ki of 3.5, 5.0, 6.5 and 8.5 × 10
−6 M for
peptides A5, A6, A7 and A8, respectively.
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were calculated and are presented in Table 1. The absolute
values of the Kis are appreciably different to those obtained
using the pull-down assays presented above, presumably due to
different protocols and conditions employed. However it is
notable that the wt Ad12 peptide (A5) binds to CtBP1 1.9 fold
more tightly than the acetylated version (A6) which is in good
agreement with the 1.4-fold tighter binding determined using
the pull-down assay. Additionally the wt Ad5 peptide (A7)
binds 1.5-fold more tightly than the comparable acetylated
peptide which is a similar value to that determined using the
pull-down assay.
The results of the ELISAs using GST-CtBP2 follow a similar
pattern to that for CtBP1 in that acetylation reduces the affinity
of the peptide for the CtBP protein by 1.6-fold (A5 compared to
A6) and 2-fold (A7 compared to A8) (Fig. 3B). Interestingly,
however, the affinity of all peptides for CtBP1 is considerablygreater than for CtBP2 (3- to 5-fold depending on the peptide)
(Table 1).
Structural properties of Ad12 E1A peptides
As a consequence of lysine acetylation, the relative binding
affinity of peptides equivalent to the C terminus of Ad E1As for
CtBP is lower than for non-acetylated counterparts (Table 1). It
was, therefore, of considerable interest to assess whether this
causes an alteration in the three-dimensional structure of the
peptide (and by implication, the C-terminus of intact E1A).
However, the notion that acetylation interferes with binding
merely as a result of steric hindrance could not be ruled out.
To obtain as much information as possible, the peptides were
examined by 1H NMR spectroscopy and one-dimensional
spectra obtained for the Ad 12 peptides confirm the absence
(Fig. 4A) and presence (Fig. 4B) of an acetyl moiety at
Table 1
Kis calculated from the data presented in Fig. 3
Binding to Peptide a Ki (μM)
b r n
CtBP1 A5 0.187 ± 0.02 0.992 6
A6 0.370 ± 0.03 0.982 6
A7 0.499 ± 0.07 0.982 6
A8 0.766 ± 0.11 0.979 6
CtBP2 A5 0.680 ± 0.08 0.986 6
A6 1.100 ± 0.14 0.989 6
A7 1.800 ± 0.19 0.988 6
A8 3.730 ± 0.85 0.944 6
r = regression coefficient (goodness of fit).
n = number of replicates.
a See Fig. 1 for peptide sequences.
b Calculated using the standard binding equation as described in the legend to
Fig. 2 and Molloy et al., (1998).
Fig. 3. Inhibition of binding interactions between AdE1A and CtBP in the
presence of acetylated and non-acetylated AdE1A synthetic peptides. The ability
of synthetic peptides equivalent to the C-terminal regions of Ad12E1A and
Ad5E1A to inhibit the interaction of Ad12E1A and CtBP1 and CtBP2 was
assessed using ELISAs (see Materials and methods). The averaged data from six
experiments (±SD) for peptides A5 (▪), A6 (▴), A7 (▾) andA8 (x) is presented.
A, CtBP1; B, CtBP2. The lines represent best fit of the data by the standard
binding equation as described in the legend to Fig. 2 and in Molloy et al. (1998).
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obtained for Ad5 peptides were significantly overlapped
precluding further detailed spectroscopic analysis. In contrast,
two-dimensional TOCSY and NOESY spectra obtained for the
acetylated form of the Ad12 peptide showed good spectral
dispersal and the cross-peaks observed in the amide-α region of
a NOESY spectrum (mixing time, 200 ms), along with a
summary of the observed NOEs for this peptide are shown in
Fig. 5.
We have already described in detail the structure for the
wild-type Ad12 peptide (Molloy et al., 1998). This was re-
assessed here (Fig. 6) to allow direct comparison between the
type and number of NOEs (Fig. 6A) and structures calculatedfor the wild-type (Fig. 6B) and acetylated (Fig. 6C) forms of
the Ad12 peptide. In our re-calculations, we found that the
structure for the wild-type peptide was equivalent to that
described previously, such that residues between Val254 and
Arg262 adopt a series of overlapping β-turns (Molloy et al.,
1998; Figs. 6B and D).
As expected, the conformation over residues Glu247-Glu251
and Pro263-Asn266 within the acetylated form of the Ad12
peptide is poorly defined in the absence of medium and long
range NOEs and structures calculated for this peptide display
evidence of significant fraying over the N- and C-terminal
regions (Figs. 6C and E). Analysis of the initial calculated
structures indicated that two intra-molecular hydrogen bonds,
each occurring over a CO(i)HN(i + 3) donor/acceptor pattern, and
which correlated with low temperature dependence of the
backbone amide proton chemical shifts for Asp257 and Val260
(Fig. 5B), are formed within the acetylated Ad12 peptide. These
were included in the final calculations for this peptide, and
fifteen superimposed structures are illustrated (Fig. 6C). In
contrast, the wild-type form of the peptide adopts a CO(i)
HN(i + 3) donor/acceptor hydrogen bonding pattern involving
three residues, namely Asp257, Val260 and Lys 261 (Molloy et al.,
1998).
The observed NOEs dαN (i, i + 2) Val
256-Leu258, Asp257-
Ser259, Leu258-Val260, Ser259-Lys261, Val260-Arg262, dNN(i,
i + 2) Val256-Leu258, Leu258-Val260, and a weak cross-peak, dN
(i, i + 3) between Val254 and Asp257 (Fig. 5A) indicate that the
backbone of the acetylated Ad12 peptide displays conforma-
tional preference between residues Val254 and Val260 on the
NMR timescale. This is exemplified by good alignment
between the superposed structures (Fig. 6C) and derive type I
β-turns over the sequence Val254-Asp257, where the average
distance C-αi(Val
254) to C-αi + 3(Asp
257) is 5.2 Å (Fig. 6C).
Again, the side chain methyl groups of Val256, Leu258 and
Val260 within the acetylated peptide form a hydrophobic cluster,
as found in the wild-type form of the peptide. In the absence of
the NOEs dαN and dβN(i, i + 2) Ser
259-AcK261 Val260-Arg262
(Fig. 5B) within spectra recorded for the acetylated peptide,
equivalent to dαN and dβN(i, i + 2) Ser
259-K261 Val260-Arg262
within the wild-type peptide, the corresponding β-turns Ser259-
AcK261 and Val260-Arg262 are disrupted within the acetylated
Fig. 4. NMR analysis of Ad12 E1A peptides. One-dimensional 1H NMR spectra were recorded on 300 μM samples of wild-type (A) and acetylated (B) Ad12 peptide
at 285 K in 25 mM [2H]Tris, adjusted to pH 7.4 with 2HCl. Assignments for Lys261(↓) and AcK261 (●) labeled using the sequence of Ad12 266-aa E1A were
determined from separate two-dimensional TOCSY experiments.
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interactions with CtBP1 and CtBP2 not only by virtue of the
presence of the acetyl moiety and neutralization of the positive
charge, but also by causing disruption of the β-turn structure
around the binding site (Figs. 6C and E).
Discussion
CtBP was first isolated on the basis of its interaction with
AdE1A. The major binding site has been mapped to the highly
conserved PXDLS motif present very close to the C terminus in
conserved region 4 (Boyd et al., 1993; Schaeper et al., 1995).
However, it has been shown that mutation of amino acids
distinct from these five amino acids can have an effect on the
interaction (Molloy et al., 1998). Furthermore, it has been
demonstrated that CtBP1 has a higher affinity for full-length
Ad12E1A than for the C-terminal 77 amino acids and this, in
turn, binds more strongly than does a 20-amino-acid peptide
just encompassing the binding site. Furthermore, it has been
shown that post-translational modification can play a large part
in regulating the activities of CtBP and interaction with partner
proteins. For example, phosphorylation of CtBP by p21-
activated kinase (Pak1) regulates CtBP subcellular distribution
and repressor activity (Barnes et al., 2003). Similarly,
phosphorylation of CtBP by homeodomain interacting protein
kinase 2 (HIPK2) appears to mediate the level of expression of
CtBP by determining rate of protein degradation (Zhang et al.,
2003). A further modification which has been suggested to be of
particular significance in regulating interaction of CtBP with
partner proteins is the acetylation of lysine residue(s) just C-terminal to the PXDLS motif in target proteins. These amino
acids are present in the majority of CtBP binding proteins,
exceptions being, for example, the viral protein EBNA3C, CtIP
and mouse Ikaros. Acetylation of Ad5E1A lysine239 by CBP,
Gcn5 or P/CAF has been suggested to result in a marked
reduction of affinity for CtBP as observed in pull-down assays
(Zhang et al., 2000). However, using a peptide mimetic
approach we have observed an approximately 1.5- to 2-fold
difference in Ki of acetylated and non-acetylated peptides for
inhibition of binding of Ad12E1A to CtBP (Figs. 2 and 3, Table
1). We suggest, therefore, that the effects of acetylation are
subtle rather than producing an all or nothing effect as has been
suggested (Zhang et al., 2000). To some extent consistent with
this proposition, Madison et al. (2002) have found that
acetylation of lysine residues has no effect on the interaction
of AdE1A with CtBP.
It is interesting to note that the Kis for peptides inhibiting
binding to CtBP2 were, in each case, greater than those for
CtBP1. Whether this indicates that CtBP1 is a preferred target
for AdE1Awill have to await a more detailed analysis, but it is
clear for animal studies that the two CtBP homologues have
quite distinct biological functions (Hildebrand and Soriano,
2002), and it is therefore possible that it is more important for
virus replication that CtBP1 is bound/inactivated by AdE1A
than CtBP2.
We have considered the possibility that acetylation, as well
as neutralizing the positive change on the lysine, will also
disrupt the structural integrity of the CtBP binding site. We have
previously shown that peptides equivalent to the C-terminal
sequences of both Ad5 and Ad12E1As (when dissolved in TFE/
Fig. 5. 1H NMR assignments for the 20-aa acetylated Ad12 peptide. (A) The amide region of a NOESY spectrum (mixing time, 200-ms duration) collected on a sample
of the 20-aa Ad12 E1A acetylated peptide (at a concentration of 5 mg/ml) of sequence 247EEEREQTVPVDLSVAcKRPRCN266 in 50% (v/v) TFE/40% H2O/10%
2H2O, pH 5.5, at 285 K is presented. NOEs corresponding to cross-peaks within a single residue are labeled with a single number corresponding to those positions in
the sequence of full-length Ad12 wild-type 266-aa E1A. NOEs that define medium range contacts of the type dN(i, i + 2), dN(i, i + 2) and dN(i, i + 3) are labeled with
both residue numbers. (B) Summary of NOEs, 3JNH coupling constants and backbone amide proton temperature shift coefficients observed for the acetylated Ad12
peptide based on the numbering system of Ad12 wild-type 266-aa E1A. The sequential (i + 1) and medium range (i + 2 and i + 3) NOEs are represented by the
thickness of the bars. For Pro residues, the –CH2 signals substitute for the NH protons. More than 95% of proline adopts a trans backbone conformation.
3JNH coupling
constants were calculated from two-dimensional COSY spectra in 50% d3-TFE, pH 5.5, at 285 K.
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tions seen as a series of β-turns which extend from Thr252–
Lys261 in Ad12 peptides (Molloy et al., 1998). Three-
dimensional structures for the acetylated Ad12 peptide have
now been calculated from 1H NMR data in the presence of TFE
as a co-solvent with water. It is well-documented that TFE/water
mixtures promote hydrogen bond formation and that observation
of a β-turn conformation present within structures of syntheticpeptides is not uncommon (Molloy et al., 1998). Data presented
here illustrate that the structure adopted by the Ad12 E1A
peptide carrying AcK261 is comparable in the N-terminal half to
that formed within the wild-type counterpart and the major
structural differences between these peptides are entirely due to
post-translational modification. The notable difference in
structure relates to the absence of certain NOEs within spectra
for the acetylated isoform. This changes the hydrogen bonding
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Fig. 7. Synthetic peptide interactions with CtBP3/BARS. A portion of the crystal
structure for CtBP3/BARS in the presence of the 7-residue synthetic peptide of
sequence PIDLSKK is illustrated as a protein cartoon of α-helix (red), β-strand
(yellow) and loop (black) conformations. The amino acids within CtBP3/BARS
A41, F42, C43, E50 and H52 shown in grey are labeled using the single letter
abbreviation and position in the sequence of CtBP3/BARS. Residues within the
synthetic peptide are shown (red) using the three-letter amino acid abbreviation
and position in the sequence of the peptide.
123D. Molloy et al. / Virology 355 (2006) 115–126pattern from a CO(i)HN(i + 3) donor/acceptor involving Asp
257,
Val260 and Lys 261 within the wild-type isoform to CO(i)HN(i + 3)
donor/acceptor Asp257 and Val260 in the acetylated form
inducing a more random backbone conformation over the region
Val260-Arg262. Differences in the actual PXDLS motifs in the
acetylated and non-acetylated peptides are not great (Fig. 6)
although Ser259 appears to be somewhat less well integrated into
the β-turns than is the case for the non-acetylated peptide.
However, C-terminal to the PXDLS motif the β-turn structure
breaks down completely in the acetylated peptide. It seems
therefore that CtBP binding optimally requires a series of β-
turns extending C-terminal to PXDLS and the actual binding
probably encompasses seven amino acids (PXDLSXK). We
suggest therefore that a combination of structural integrity
resulting in the β-turn conformation over the whole site and
appropriate side chains is required for optimal interaction
between AdE1A (and probably all PXDLS containing proteins)
and CtBP. A recent study has shown that similar arguments can
be advanced to describe interactions of the N-terminal region of
AdE1A where a predicted α-helix is required for multiple
interactions, but these are then modulated by amino acid side
chain recognition (Rasti et al., 2005).
Inspection of the crystal structure of rat CtBP3/BARS, which
is approximately 65% identical to human CtBP1 at the amino
acid level, complexed to a synthetic peptide containing the
PXDLS motif (Fig. 7) provides, by analogy, a partial insight
into the molecular interactions formed between E1A and
CtBP1. Within CtBP3/BARS, residues Ala41, Phe42 and
Cys43 form contacts with amino acids Ile2, Asp3 and Leu4,
which adopt a β-conformation within the peptide used in that
study (Fig. 7). Additional contacts are made between amino
acids Glu50 and His52 within CtBP and Leu4 and Lys6 within
the peptide. It was also of considerable interest to observe that
the PIDLSKK peptide adopts a β-conformation when bound to
CtBP3/BARS (Fig. 7), albeit to a significantly lesser extent than
that formed in the Ad12 peptides described here and previously
(Molloy et al., 1998). This probably occurs by virtue of the
shorter amino acid sequence present within the PIDLSKK
peptide compared to the 20-aa Ad12 peptide. As a consequence,
the Ad12 peptide possesses higher intrinsic propensity to form
regular secondary structural elements. Furthermore, it can be
readily surmised that acetylation of lysine at either position 6 or
7 within the PIDLSKK peptide would lead to considerable
steric hindrance. These observations confirm the data presented
here and elsewhere (Molloy et al., 1998, 2001; Zhang et al.,
2000) that full structural integrity of the β-turn conformation isFig. 6. The calculated structures for the wild-type and acetylated Ad12 peptides. (A) A
the wild-type (black bars) and acetylated (white bars) forms of the Ad12 peptide. (B) T
structures are shown out of the 40 that converged from the 100 calculated inclusive of
for Ser259, 1.9 ppb/K; Val260, 2.5 ppb/K, Lys261, 2.0 ppb/K, are shown. Both the bac
single-letter abbreviation and position in the sequence of Ad12 266-aa E1A. In the f
mean structure were 0.67 ± 0.16 Å for all atoms for the residues between Val254 and A
violated by more than 0.5 Å. (C) The backbone and side-chain non-hydrogen atoms w
of two hydrogen bonds (Ser259, 2.1 ppb/K; Val260, 2.3 ppb/K) are presented with amin
sequence of Ad12 266-aa E1A. In the final 47 structures calculated, the average root m
for the residues between Val254 and Val260 and 1.65 ± 0.2 Å for all the non-hydrogen
backbone structures of the peptides shown in panels B and C respectively.required for interactions of the PXDLSXK motif with CtBP and
that post-translational modification reduces binding affinity
through steric hindrance and disruption of structural integrity
within the peptide. However, we have found that acetylation of
the lysine residue did not cause the total abolition of binding
reported previously by Zhang et al. (2000). This may be due to
differences in the serotype of the AdE1A examined (Ad12
compared to Ad5) or to differences in the methods used. Results
from this and previous studies (Molloy et al., 1998, 2000)
indicate that the β-turn confirmation of synthetic peptides
encompassing the C-terminal region of AdE1A does not extend
to the very C-terminus and does not include the nuclear
localization signal. It seems reasonable to conclude therefore
that the effect of acetylation on binding to importin-α3
(Madison et al., 2002) is a direct result of the neutralization of
the positive charge on the lysine rather than loss of a structured
binding motif. The very close juxtaposition of binding sites
for CtBP and importin-α3 suggests that interaction with both
does not occur simultaneously, although at present we have
no evidence to confirm this. However, it seems likely thatsummary of the number and type of NOEs is illustrated in graphical format for
he calculated structure for the 20-aa wild-type Ad12 peptide. Fifteen superposed
three COiHi + 3 hydrogen bonds as defined by low temperature shift coefficients
kbone and side chain atoms are presented and amino acids are labeled using the
inal 47 structures calculated, the average root mean square differences from the
rg262 and 1.50 ± 0.12 Å for all the non-hydrogen atoms. No distance restraint was
ithin fifteen superposed structures for the acetylated Ad12 peptide in the presence
o acids labeled using the single-letter abbreviation according to the position in the
ean square differences from the mean structure were 0.96 ± 0.18 Å for all atoms
atoms. No distance restraint was violated by more than 0.5 Å. (D) and (E) Mean
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nuclear localization of AdE1A as well as its C-terminal
structure and extent of interaction with CtBP. It is interesting
to note that the sequences at the C-terminus of Ad5E1A
and Ad12E1A (encompassing the CtBP binding site and
NLS) are very similar to a CtBP binding site in the Droso-
phila protein snail (Ad5E1A:QPLDLSCKRPR; Ad12E1A:
VPVDLSVKRPR; snail: QPQDLSLKRRGR). Whether this
homology indicates that the NLS present in snail is adjacent to
the CtBP binding site or whether the CtBP binding site is even
more extensive than the PXDLSXK sequence suggested here is
not clear.
Materials and methods
Protein preparation
Ad12E1A was expressed in E. coli strain DH-5α from the
pKK388-1 vector, purified and re-natured as described previ-
ously (Grand et al., 1998). CtBP1 and CtBP2 were expressed in
E. coli strain TG2 from the pGEX-5X-3 vector as fusion proteins
with glutathione-S-transferase as described previously (Grand
et al., 1998). After purification using glutathione agarose beads
(Sigma), the GST-CtBP1 and GST-CtBP2 proteins were
dialyzed against 0.15 M NaCl, 50 mM Tris–HCl, pH 7.4,
1 mM DTT and stored at −80 °C until required.
Synthetic peptides
Four synthetic peptides identical in sequence to the C
terminal regions of wild-type Ad12E1A and Ad5E1A or
carrying N-ε-acetyl lysine (Aly, AcK) in place of lysine at
position 261 and 286 in Ad12E1A and Ad5E1A, respectively,
were used in this study (Fig. 1). They were synthesized using
standard f-moc procedures and purified by high-performance
liquid chromatography on a Vydac C18 column eluted with a
gradient of acetonitrile (0–60%) containing 0.1% (v/v)
trifluoroacetic acid. The molecular weights of synthetic peptides
were confirmed by mass spectroscopy and compared with the
calculated Mr evaluated for each using the Compute pI/Mw
algorithm available on the Swiss-Prot/TrEMBL website (http://
us.expasy.org/tools/pi_tool.html).
GST ‘pull-down’ assays
Purified Ad12 E1A (2 μg in 10 μl of NETN buffer (50 mM
Tris–HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet
P-40)) was incubated with GST-CtBP1 (2 μg in 30 μl of NETN
buffer) at 4 °C in a total volume of 200 μl NETN buffer. After
1 h, 50 μl glutathione agarose beads (Sigma), pre-blocked with
5% skimmed milk powder was added and the mixture was
agitated for a further 90 min at 4 °C. Agarose beads were
retrieved by centrifugation and washed three times with NETN
buffer. 5 mM glutathione (15 μl) was then added, and released
proteins were mixed with SDS-polyacrylamide gel electropho-
resis sample buffer. After SDSPAGE and Western blotting,
Ad12 E1A was detected using a mouse monoclonal antibody(5D02) described previously (Grand et al., 1998). The effect of
synthetic peptides on Ad12 E1A-CtBP1 interactions was
monitored by incubating peptides with GST-CtBP1 at concen-
trations of 5, 25, 50 and 100 μg for 1 h prior to the addition of
Ad12E1A. Control experiments were performed in the absence
of GST-CtBP1. The densitometric scanning of the Western blots
was carried out using a BioRad GS-800 Calibrated Densitom-
eter, and care was taken that all readings were in the linear range.
ELISAs
ELISAs were used for the quantitative analysis of the effects
of acetylated and non-acetylated peptides on the interactions of
Ad12E1A with CtBP1 and CtBP2. ELISAs were performed
essentially as described previously (Molloy et al., 1998, 2000,
2001). Briefly ELISA plates were coated with Ad12E1A
(0.025 μg per well). Purified GST-CtBP1 and GST-CtBP2
(1.75 μg/well) were incubated with decreasing concentrations
of peptides (Fig. 1) for 1 h at room temperature. The GST-CtBP/
peptide mixtures were then added to the ELISA plates. The
amount of GST-CtBP bound to the Ad12E1A on the plates was
determined using an antibody against GST (Amersham). Kis
were calculated using the standard binding equation (Molloy et
al., 1998, 2000, 2001).
NMR spectroscopy
All NMR spectra were recorded using a Bruker AMX 500
MHz spectrometer. Solutions of peptides were between 4 and
8mM in concentration, routinely at pH5.5 in 50% (v/v) d3-TFE/
40% H2O/10%
2H2O; 5 mM
2H-DTT at 285 K. One-
dimensional 1H NMR spectra were recorded using a gated
pre-saturation pulse of 1.5-s duration (to remove the H2O
signal) for accumulation over a 5050-Hz sweep width with a
90° pulse of 5 μs. Spectra were recorded as free induction
decays (between 1024 and 2048 transients) and Fourier
transformed using a 2-Hz line broadening function (Molloy et
al., 1998).
Two-dimensional experiments were acquired with 2048 data
points in F2 with a sweep width of 11 ppm and with between
480 and 608 rows in F1. The water resonance was suppressed
by very weak pre-saturation (1.5 s) or through the WATER-
GATE sequence, with solvent artefacts suppressed using pulsed
field gradients. Total correlation spectroscopy (TOCSY) used
an MLEV-17 mixing pulse of 60ms duration (10 kHz spin
locking field). Nuclear Overhauser effect spectroscopy
(NOESY) experiments were performed using a mixing time
of 200-ms duration. 128 transients were collected for TOCSY,
NOESYand Double Quantum coherence spectroscopy (COSY)
experiments (Molloy et al., 1998).
NMR assignments and structural calculations
Assigment of proton signals in TOCSY experiments to
identify spin systems within individual residues were coupled to
sequential (dαNi, i + 1) and inter-residue (dαNi, i + 2 and dαNi,
i + 3) NOE cross-peaks in NOESY spectra. For proline residues,
125D. Molloy et al. / Virology 355 (2006) 115–126the δ-CH2 protons signals were served in place of dαN signals.
The volume of each cross-peak was evaluated using SPARKY 3
(Goddard and Kneller, 2005) and/or NMRPipe (Delaglio et al.,
1995) in order to estimate distances between individual proton
signals within NOESY experiments, which were grouped into
three classes, strong (1.8–2.5Å), medium (1.8–4Å) and very
weak (1.8–6.5Å; strong and medium NOEs were allocated the
same distance constraints in structural calculations). Backbone
hydrogen bonding patterns were assessed by monitoring the
linear movement of chemical shifts of backbone amide protons
with changes in temperature between 285 and 305K in TOCSY
experiments. 3JHNα coupling constants were calculated from
two-dimensional COSY experiments.
The structures of peptides were determined using X-PLOR
version 3.851 (Brünger, 1992), initially using the dg_sub_
embed subroutine to embed the CA, HA, N, HN, CB* and CG*
atoms. The remaining atoms were template fitted and the atomic
co-ordinates were allowed to evolve under the applied NOE
distance, 3JHNα dihedral and hydrogen bonding constraints
using the dgsa and refine simulated annealing subroutines.
From 100 structures generated, approximately 25–30 were
discarded (wrong-handedness in the distance geometry routine).
Twenty-five remaining structures were chosen with no viola-
tions of the applied NOEs of greater than 0.5Å in the accept
subroutine. The X-PLOR topology, connectivities and atomic
nomenclature for acetyllysine (Aly) were obtained from http://
xray.bmc.uu.se.gerard.hicup/ALY.
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